CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Janssen Biotech, Inc. v. Amgen Inc.

1:22-cv-01549

Overview

Case Number 1:22-cv-01549
Filing Date 2022-11-29
Status Terminated
Termination Date 2023-05-23
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Amgen Inc. Operating Company

Represented By

10 Attorneys Listed

Siegmund Y. Gutman

Email: sgutman@proskauer.com

Scott P. Cooper

Email: scooper@proskauer.com

Robert W. Whetzel

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Kevin J. Perra

Email: kperra@proskauer.com

James A. High

Email: jhigh@amgen.com

Dennis J. Smith

Email: dennis.smith@amgen.com

David M. Hanna

Email: dhanna@proskauer.com

Alaina M. Whitt

Email: awhitt@amgen.com

Nicole Kathleen Pedi

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7844
Fax: +1 (302) 498-7701

Richards, Layton & Finger, PA, One Rodney Square

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Plaintiff

Janssen Biotech, Inc. Operating Company

Represented By

4 Attorneys Listed

Michael R. Seringhaus

Email: michael.seringhaus@lw.com

Inge A. Osman

Email: inge.osman@lw.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): πŸ‡¨πŸ‡¦ Canada CN πŸ‡©πŸ‡ͺ Germany πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6902734
Anti-IL-12 antibodies and compositions thereof
Filed: 2001-08-01
Issued: 2005-06-07
Expired (Term Ended) +785d PTA
Expires: 2023-09-25
US10961307
Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody
Filed: 2019-09-24
Issued: 2021-03-30
Active (12.8 yrs remaining)
Expires: 2039-09-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+785 days) / Cellect Scrutiny β€” Over 785 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

12

Dispositive

2

Granted

0

Denied

0

Pending / Review

11

Motions by Category

Procedural / Extension Motion 10 Motion for Preliminary Injunction / TRO 2

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending / Under Review
Preliminary Injunction
Entry #35 • 2023-03-06 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
Preliminary Injunction
Entry #24 • 2023-03-01 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation to EXTEND Time
Entry #95 • 2023-05-12 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation to EXTEND Time
Entry #87 • 2023-04-21 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #73 • 2023-03-23 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation-General (See Motion List for Stipulation to Extend Time)
Entry #68 • 2023-03-17 Document →

Docket Entries

(136 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Amgen Inc. ( Filing fee $ 402, receipt number ADEDC-4014567.) - filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Exhibit H-N, # 3 Civil Cover Sheet) (vfm) (Entered: 11/30/2022)

Entry #1 • 2022-11-29
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Amgen Inc. ( Filing fee $ 402, receipt number ADEDC-4014567.) - filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Exhibit H-N, # 3 Civil Cover Sheet) (vfm) (Entered: 11/30/2022)

Entry #1 • 2022-11-29
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Amgen Inc. ( Filing fee $ 402, receipt number ADEDC-4014567.) - filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Exhibit H-N, # 3 Civil Cover Sheet) (vfm) (Entered: 11/30/2022)

Entry #1 • 2022-11-29
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Amgen Inc. ( Filing fee $ 402, receipt number ADEDC-4014567.) - filed by Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Exhibit H-N, # 3 Civil Cover Sheet) (vfm) (Entered: 11/30/2022)

Entry #1 • 2022-11-29
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 11/30/2022)

Entry #2 • 2022-11-29
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc